Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials Article Swipe
Yuanyuan Wang
,
Tanja R. Zijp
,
Muh. Akbar Bahar
,
Janwillem Kocks
,
Bob Wilffert
,
Eelko Hak
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/jac/dky326
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/jac/dky326
Prophylactic antibiotics were effective in preventing COPD exacerbations and improving quality of life among stable patients with moderate to severe COPD. The choice of prophylactic antibiotics should be analysed and considered case by case, especially for long and continuous use.
Related Topics
Concepts
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1093/jac/dky326
- https://academic.oup.com/jac/article-pdf/73/12/3231/26651224/dky326.pdf
- OA Status
- bronze
- Cited By
- 11
- References
- 42
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2892109273
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2892109273Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/jac/dky326Digital Object Identifier
- Title
-
Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trialsWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-07-21Full publication date if available
- Authors
-
Yuanyuan Wang, Tanja R. Zijp, Muh. Akbar Bahar, Janwillem Kocks, Bob Wilffert, Eelko HakList of authors in order
- Landing page
-
https://doi.org/10.1093/jac/dky326Publisher landing page
- PDF URL
-
https://academic.oup.com/jac/article-pdf/73/12/3231/26651224/dky326.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/jac/article-pdf/73/12/3231/26651224/dky326.pdfDirect OA link when available
- Concepts
-
Medicine, Antibiotics, Exacerbation, COPD, Randomized controlled trial, Azithromycin, Internal medicine, Relative risk, Adverse effect, Meta-analysis, Erythromycin, Intensive care medicine, Confidence interval, Microbiology, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
11Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 1, 2022: 1, 2021: 3, 2020: 2Per-year citation counts (last 5 years)
- References (count)
-
42Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2892109273 |
|---|---|
| doi | https://doi.org/10.1093/jac/dky326 |
| ids.doi | https://doi.org/10.1093/jac/dky326 |
| ids.mag | 2892109273 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/30189002 |
| ids.openalex | https://openalex.org/W2892109273 |
| fwci | 1.72860971 |
| mesh[0].qualifier_ui | Q000008 |
| mesh[0].descriptor_ui | D000900 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | administration & dosage |
| mesh[0].descriptor_name | Anti-Bacterial Agents |
| mesh[1].qualifier_ui | Q000009 |
| mesh[1].descriptor_ui | D000900 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | adverse effects |
| mesh[1].descriptor_name | Anti-Bacterial Agents |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D019072 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Antibiotic Prophylaxis |
| mesh[3].qualifier_ui | Q000008 |
| mesh[3].descriptor_ui | D017963 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | administration & dosage |
| mesh[3].descriptor_name | Azithromycin |
| mesh[4].qualifier_ui | Q000009 |
| mesh[4].descriptor_ui | D017963 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | adverse effects |
| mesh[4].descriptor_name | Azithromycin |
| mesh[5].qualifier_ui | Q000517 |
| mesh[5].descriptor_ui | D001424 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | prevention & control |
| mesh[5].descriptor_name | Bacterial Infections |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D018450 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Disease Progression |
| mesh[7].qualifier_ui | Q000008 |
| mesh[7].descriptor_ui | D004917 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | administration & dosage |
| mesh[7].descriptor_name | Erythromycin |
| mesh[8].qualifier_ui | Q000009 |
| mesh[8].descriptor_ui | D004917 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | adverse effects |
| mesh[8].descriptor_name | Erythromycin |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006760 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Hospitalization |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D017063 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Outcome Assessment, Health Care |
| mesh[12].qualifier_ui | Q000150 |
| mesh[12].descriptor_ui | D029424 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | complications |
| mesh[12].descriptor_name | Pulmonary Disease, Chronic Obstructive |
| mesh[13].qualifier_ui | Q000382 |
| mesh[13].descriptor_ui | D029424 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | microbiology |
| mesh[13].descriptor_name | Pulmonary Disease, Chronic Obstructive |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D011788 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Quality of Life |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D016032 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Randomized Controlled Trials as Topic |
| mesh[16].qualifier_ui | Q000008 |
| mesh[16].descriptor_ui | D000900 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | administration & dosage |
| mesh[16].descriptor_name | Anti-Bacterial Agents |
| mesh[17].qualifier_ui | Q000009 |
| mesh[17].descriptor_ui | D000900 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | adverse effects |
| mesh[17].descriptor_name | Anti-Bacterial Agents |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D019072 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Antibiotic Prophylaxis |
| mesh[19].qualifier_ui | Q000008 |
| mesh[19].descriptor_ui | D017963 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | administration & dosage |
| mesh[19].descriptor_name | Azithromycin |
| mesh[20].qualifier_ui | Q000009 |
| mesh[20].descriptor_ui | D017963 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | adverse effects |
| mesh[20].descriptor_name | Azithromycin |
| mesh[21].qualifier_ui | Q000517 |
| mesh[21].descriptor_ui | D001424 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | prevention & control |
| mesh[21].descriptor_name | Bacterial Infections |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D018450 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Disease Progression |
| mesh[23].qualifier_ui | Q000008 |
| mesh[23].descriptor_ui | D004917 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | administration & dosage |
| mesh[23].descriptor_name | Erythromycin |
| mesh[24].qualifier_ui | Q000009 |
| mesh[24].descriptor_ui | D004917 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | adverse effects |
| mesh[24].descriptor_name | Erythromycin |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D006760 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Hospitalization |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D006801 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Humans |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D017063 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Outcome Assessment, Health Care |
| mesh[28].qualifier_ui | Q000150 |
| mesh[28].descriptor_ui | D029424 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | complications |
| mesh[28].descriptor_name | Pulmonary Disease, Chronic Obstructive |
| mesh[29].qualifier_ui | Q000382 |
| mesh[29].descriptor_ui | D029424 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | microbiology |
| mesh[29].descriptor_name | Pulmonary Disease, Chronic Obstructive |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D011788 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Quality of Life |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D016032 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Randomized Controlled Trials as Topic |
| type | review |
| title | Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials |
| awards[0].id | https://openalex.org/G1534461767 |
| awards[0].funder_id | https://openalex.org/F4320322725 |
| awards[0].display_name | |
| awards[0].funder_award_id | 201506010259 |
| awards[0].funder_display_name | China Scholarship Council |
| biblio.issue | 12 |
| biblio.volume | 73 |
| biblio.last_page | 3243 |
| biblio.first_page | 3231 |
| topics[0].id | https://openalex.org/T10143 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994999766349792 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Chronic Obstructive Pulmonary Disease (COPD) Research |
| topics[1].id | https://openalex.org/T13770 |
| topics[1].field.id | https://openalex.org/fields/36 |
| topics[1].field.display_name | Health Professions |
| topics[1].score | 0.9987000226974487 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3604 |
| topics[1].subfield.display_name | Emergency Medical Services |
| topics[1].display_name | Pediatric health and respiratory diseases |
| topics[2].id | https://openalex.org/T12418 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9930999875068665 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Respiratory and Cough-Related Research |
| funders[0].id | https://openalex.org/F4320320351 |
| funders[0].ror | https://ror.org/051x4wh35 |
| funders[0].display_name | Commonwealth Scholarship Commission |
| funders[1].id | https://openalex.org/F4320320933 |
| funders[1].ror | https://ror.org/012p63287 |
| funders[1].display_name | Rijksuniversiteit Groningen |
| funders[2].id | https://openalex.org/F4320322725 |
| funders[2].ror | https://ror.org/04atp4p48 |
| funders[2].display_name | China Scholarship Council |
| is_xpac | False |
| apc_list.value | 2627 |
| apc_list.currency | GBP |
| apc_list.value_usd | 3222 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9086759090423584 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C501593827 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7519876956939697 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q12187 |
| concepts[1].display_name | Antibiotics |
| concepts[2].id | https://openalex.org/C2777014857 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7040910124778748 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1383410 |
| concepts[2].display_name | Exacerbation |
| concepts[3].id | https://openalex.org/C2776780178 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6861869096755981 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q199804 |
| concepts[3].display_name | COPD |
| concepts[4].id | https://openalex.org/C168563851 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6423915028572083 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[4].display_name | Randomized controlled trial |
| concepts[5].id | https://openalex.org/C2778907293 |
| concepts[5].level | 3 |
| concepts[5].score | 0.6373487114906311 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q165399 |
| concepts[5].display_name | Azithromycin |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5916557312011719 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C82789193 |
| concepts[7].level | 3 |
| concepts[7].score | 0.5607929825782776 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2142611 |
| concepts[7].display_name | Relative risk |
| concepts[8].id | https://openalex.org/C197934379 |
| concepts[8].level | 2 |
| concepts[8].score | 0.545055627822876 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[8].display_name | Adverse effect |
| concepts[9].id | https://openalex.org/C95190672 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4776657521724701 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q815382 |
| concepts[9].display_name | Meta-analysis |
| concepts[10].id | https://openalex.org/C2780206985 |
| concepts[10].level | 3 |
| concepts[10].score | 0.4255443811416626 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q213511 |
| concepts[10].display_name | Erythromycin |
| concepts[11].id | https://openalex.org/C177713679 |
| concepts[11].level | 1 |
| concepts[11].score | 0.4094564616680145 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[11].display_name | Intensive care medicine |
| concepts[12].id | https://openalex.org/C44249647 |
| concepts[12].level | 2 |
| concepts[12].score | 0.27906137704849243 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[12].display_name | Confidence interval |
| concepts[13].id | https://openalex.org/C89423630 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[13].display_name | Microbiology |
| concepts[14].id | https://openalex.org/C86803240 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[14].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9086759090423584 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/antibiotics |
| keywords[1].score | 0.7519876956939697 |
| keywords[1].display_name | Antibiotics |
| keywords[2].id | https://openalex.org/keywords/exacerbation |
| keywords[2].score | 0.7040910124778748 |
| keywords[2].display_name | Exacerbation |
| keywords[3].id | https://openalex.org/keywords/copd |
| keywords[3].score | 0.6861869096755981 |
| keywords[3].display_name | COPD |
| keywords[4].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[4].score | 0.6423915028572083 |
| keywords[4].display_name | Randomized controlled trial |
| keywords[5].id | https://openalex.org/keywords/azithromycin |
| keywords[5].score | 0.6373487114906311 |
| keywords[5].display_name | Azithromycin |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.5916557312011719 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/relative-risk |
| keywords[7].score | 0.5607929825782776 |
| keywords[7].display_name | Relative risk |
| keywords[8].id | https://openalex.org/keywords/adverse-effect |
| keywords[8].score | 0.545055627822876 |
| keywords[8].display_name | Adverse effect |
| keywords[9].id | https://openalex.org/keywords/meta-analysis |
| keywords[9].score | 0.4776657521724701 |
| keywords[9].display_name | Meta-analysis |
| keywords[10].id | https://openalex.org/keywords/erythromycin |
| keywords[10].score | 0.4255443811416626 |
| keywords[10].display_name | Erythromycin |
| keywords[11].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[11].score | 0.4094564616680145 |
| keywords[11].display_name | Intensive care medicine |
| keywords[12].id | https://openalex.org/keywords/confidence-interval |
| keywords[12].score | 0.27906137704849243 |
| keywords[12].display_name | Confidence interval |
| language | en |
| locations[0].id | doi:10.1093/jac/dky326 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S124275759 |
| locations[0].source.issn | 0305-7453, 1460-2091 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0305-7453 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Antimicrobial Chemotherapy |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| locations[0].source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/jac/article-pdf/73/12/3231/26651224/dky326.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Antimicrobial Chemotherapy |
| locations[0].landing_page_url | https://doi.org/10.1093/jac/dky326 |
| locations[1].id | pmid:30189002 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | The Journal of antimicrobial chemotherapy |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/30189002 |
| locations[2].id | pmh:oai:pure.rug.nl:openaire/39dfe349-b8e1-482e-a3c3-1f6c31d207f9 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400420 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | University of Groningen research database (University of Groningen / Centre for Information Technology) |
| locations[2].source.host_organization | https://openalex.org/I169381384 |
| locations[2].source.host_organization_name | University of Groningen |
| locations[2].source.host_organization_lineage | https://openalex.org/I169381384 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | publishedVersion |
| locations[2].raw_type | info:eu-repo/semantics/publishedVersion |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | True |
| locations[2].is_published | True |
| locations[2].raw_source_name | Wang, Y, Zijp, T R, Bahar, M A, Kocks, J W H, Wilffert, B & Hak, E 2018, 'Effects of prophylactic antibiotics on patients with stable COPD : a systematic review and meta-analysis of randomized controlled trials', Journal of Antimicrobial Chemotherapy, vol. 73, no. 12, pp. 3231–3243. https://doi.org/10.1093/jac/dky326 |
| locations[2].landing_page_url | https://research.rug.nl/en/publications/39dfe349-b8e1-482e-a3c3-1f6c31d207f9 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5100423153 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5066-1654 |
| authorships[0].author.display_name | Yuanyuan Wang |
| authorships[0].countries | NL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I169381384 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| authorships[0].institutions[0].id | https://openalex.org/I169381384 |
| authorships[0].institutions[0].ror | https://ror.org/012p63287 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I169381384 |
| authorships[0].institutions[0].country_code | NL |
| authorships[0].institutions[0].display_name | University of Groningen |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yuanyuan Wang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| authorships[1].author.id | https://openalex.org/A5034454633 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6073-6376 |
| authorships[1].author.display_name | Tanja R. Zijp |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I169381384 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| authorships[1].institutions[0].id | https://openalex.org/I169381384 |
| authorships[1].institutions[0].ror | https://ror.org/012p63287 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I169381384 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | University of Groningen |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Tanja R Zijp |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| authorships[2].author.id | https://openalex.org/A5018675531 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6582-5615 |
| authorships[2].author.display_name | Muh. Akbar Bahar |
| authorships[2].countries | ID, NL |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I98301867 |
| authorships[2].affiliations[0].raw_affiliation_string | Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I169381384 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| authorships[2].institutions[0].id | https://openalex.org/I98301867 |
| authorships[2].institutions[0].ror | https://ror.org/00da1gf19 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I98301867 |
| authorships[2].institutions[0].country_code | ID |
| authorships[2].institutions[0].display_name | Hasanuddin University |
| authorships[2].institutions[1].id | https://openalex.org/I169381384 |
| authorships[2].institutions[1].ror | https://ror.org/012p63287 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I169381384 |
| authorships[2].institutions[1].country_code | NL |
| authorships[2].institutions[1].display_name | University of Groningen |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Muh Akbar Bahar |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands, Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia |
| authorships[3].author.id | https://openalex.org/A5070928097 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2760-0693 |
| authorships[3].author.display_name | Janwillem Kocks |
| authorships[3].countries | NL |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1334415907, https://openalex.org/I169381384 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of General Practice and Elderly Care Medicine, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands |
| authorships[3].institutions[0].id | https://openalex.org/I1334415907 |
| authorships[3].institutions[0].ror | https://ror.org/03cv38k47 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1334415907 |
| authorships[3].institutions[0].country_code | NL |
| authorships[3].institutions[0].display_name | University Medical Center Groningen |
| authorships[3].institutions[1].id | https://openalex.org/I169381384 |
| authorships[3].institutions[1].ror | https://ror.org/012p63287 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I169381384 |
| authorships[3].institutions[1].country_code | NL |
| authorships[3].institutions[1].display_name | University of Groningen |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Janwillem W H Kocks |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of General Practice and Elderly Care Medicine, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands |
| authorships[4].author.id | https://openalex.org/A5091328827 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8759-5697 |
| authorships[4].author.display_name | Bob Wilffert |
| authorships[4].countries | NL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I169381384 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I1334415907, https://openalex.org/I169381384 |
| authorships[4].affiliations[1].raw_affiliation_string | Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands |
| authorships[4].institutions[0].id | https://openalex.org/I1334415907 |
| authorships[4].institutions[0].ror | https://ror.org/03cv38k47 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I1334415907 |
| authorships[4].institutions[0].country_code | NL |
| authorships[4].institutions[0].display_name | University Medical Center Groningen |
| authorships[4].institutions[1].id | https://openalex.org/I169381384 |
| authorships[4].institutions[1].ror | https://ror.org/012p63287 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I169381384 |
| authorships[4].institutions[1].country_code | NL |
| authorships[4].institutions[1].display_name | University of Groningen |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Bob Wilffert |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands, Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| authorships[5].author.id | https://openalex.org/A5033079155 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-0849-7210 |
| authorships[5].author.display_name | Eelko Hak |
| authorships[5].countries | NL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I169381384 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| authorships[5].institutions[0].id | https://openalex.org/I169381384 |
| authorships[5].institutions[0].ror | https://ror.org/012p63287 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I169381384 |
| authorships[5].institutions[0].country_code | NL |
| authorships[5].institutions[0].display_name | University of Groningen |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Eelko Hak |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of PharmacoTherapy -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/jac/article-pdf/73/12/3231/26651224/dky326.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10143 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994999766349792 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Chronic Obstructive Pulmonary Disease (COPD) Research |
| related_works | https://openalex.org/W2387362575, https://openalex.org/W2358064903, https://openalex.org/W2369037096, https://openalex.org/W4386487359, https://openalex.org/W2351197079, https://openalex.org/W2056645223, https://openalex.org/W3029637430, https://openalex.org/W2369140877, https://openalex.org/W3031453801, https://openalex.org/W3029309404 |
| cited_by_count | 11 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 3 |
| counts_by_year[4].year | 2020 |
| counts_by_year[4].cited_by_count | 2 |
| counts_by_year[5].year | 2019 |
| counts_by_year[5].cited_by_count | 3 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1093/jac/dky326 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S124275759 |
| best_oa_location.source.issn | 0305-7453, 1460-2091 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0305-7453 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Antimicrobial Chemotherapy |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/jac/article-pdf/73/12/3231/26651224/dky326.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Antimicrobial Chemotherapy |
| best_oa_location.landing_page_url | https://doi.org/10.1093/jac/dky326 |
| primary_location.id | doi:10.1093/jac/dky326 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S124275759 |
| primary_location.source.issn | 0305-7453, 1460-2091 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0305-7453 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Antimicrobial Chemotherapy |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| primary_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/jac/article-pdf/73/12/3231/26651224/dky326.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Antimicrobial Chemotherapy |
| primary_location.landing_page_url | https://doi.org/10.1093/jac/dky326 |
| publication_date | 2018-07-21 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W2587954667, https://openalex.org/W2122716433, https://openalex.org/W2010967671, https://openalex.org/W1973530626, https://openalex.org/W6685222093, https://openalex.org/W6675345306, https://openalex.org/W2007903763, https://openalex.org/W1975061479, https://openalex.org/W4256679850, https://openalex.org/W2083436606, https://openalex.org/W2044782575, https://openalex.org/W2131368844, https://openalex.org/W2144974876, https://openalex.org/W1992741990, https://openalex.org/W2172046332, https://openalex.org/W2108424624, https://openalex.org/W2111983640, https://openalex.org/W2096373158, https://openalex.org/W2137969357, https://openalex.org/W2102634938, https://openalex.org/W2109191113, https://openalex.org/W6638452707, https://openalex.org/W2051910160, https://openalex.org/W2057956307, https://openalex.org/W6655238677, https://openalex.org/W1811879327, https://openalex.org/W2341636292, https://openalex.org/W2122790962, https://openalex.org/W2141317813, https://openalex.org/W2031141671, https://openalex.org/W2163467593, https://openalex.org/W2092255611, https://openalex.org/W2112162293, https://openalex.org/W2123850585, https://openalex.org/W2365138737, https://openalex.org/W2102856718, https://openalex.org/W1828345822, https://openalex.org/W2604501983, https://openalex.org/W2974087649, https://openalex.org/W2171923644, https://openalex.org/W4256713179, https://openalex.org/W2019017249 |
| referenced_works_count | 42 |
| abstract_inverted_index.be | 27 |
| abstract_inverted_index.by | 32 |
| abstract_inverted_index.in | 4 |
| abstract_inverted_index.of | 11, 23 |
| abstract_inverted_index.to | 18 |
| abstract_inverted_index.The | 21 |
| abstract_inverted_index.and | 8, 29, 37 |
| abstract_inverted_index.for | 35 |
| abstract_inverted_index.COPD | 6 |
| abstract_inverted_index.case | 31 |
| abstract_inverted_index.life | 12 |
| abstract_inverted_index.long | 36 |
| abstract_inverted_index.use. | 39 |
| abstract_inverted_index.were | 2 |
| abstract_inverted_index.with | 16 |
| abstract_inverted_index.COPD. | 20 |
| abstract_inverted_index.among | 13 |
| abstract_inverted_index.case, | 33 |
| abstract_inverted_index.choice | 22 |
| abstract_inverted_index.severe | 19 |
| abstract_inverted_index.should | 26 |
| abstract_inverted_index.stable | 14 |
| abstract_inverted_index.quality | 10 |
| abstract_inverted_index.analysed | 28 |
| abstract_inverted_index.moderate | 17 |
| abstract_inverted_index.patients | 15 |
| abstract_inverted_index.effective | 3 |
| abstract_inverted_index.improving | 9 |
| abstract_inverted_index.considered | 30 |
| abstract_inverted_index.continuous | 38 |
| abstract_inverted_index.especially | 34 |
| abstract_inverted_index.preventing | 5 |
| abstract_inverted_index.antibiotics | 1, 25 |
| abstract_inverted_index.Prophylactic | 0 |
| abstract_inverted_index.prophylactic | 24 |
| abstract_inverted_index.exacerbations | 7 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.46000000834465027 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.83011953 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |